Covid-19 Updates

You are here: Covid-19 Updates | Philippine Council for Health Research and Development

DOH, DOST, and PCHRD terminate conduct of Ivermectin clinical trial for COVID-19

DOH, DOST, and PCHRD terminate conduct of Ivermectin clinical trial for COVID-19

Upon the recommendation of the Department of Health (DOH), the Department of Science and Technology … Continue reading DOH, DOST, and PCHRD terminate conduct of Ivermectin clinical trial for COVID-19 →

June 23, 2022

Here’s how you can use the Lagundi syrup or tablet if you’re diagnosed with mild COVID-19

Here’s how you can use the Lagundi syrup or tablet if you’re diagnosed with mild COVID-19

“Following the prescribed dosages is vital to ensure that the treatment using Lagundi will render … Continue reading Here’s how you can use the Lagundi syrup or tablet if you’re diagnosed with mild COVID-19 →

March 15, 2022

Clinical Trials Reveal Lagundi Could Be Used for Mild COVID-19

Clinical Trials Reveal Lagundi Could Be Used for Mild COVID-19

Results of the clinical trials for Lagundi were presented during the Department of Science and … Continue reading Clinical Trials Reveal Lagundi Could Be Used for Mild COVID-19 →

March 7, 2022

DOST, DOH, and UPM officially launch WHO Solidarity Trial Vaccine in PH

DOST, DOH, and UPM officially launch WHO Solidarity Trial Vaccine in PH

Aiming to generate data on the efficacy of candidate vaccines against emerging variants of concern … Continue reading DOST, DOH, and UPM officially launch WHO Solidarity Trial Vaccine in PH →

December 23, 2021

DOST-PCHRD warns against the unauthorized use of the results of Lagundi study on COVID-19

DOST-PCHRD warns against the unauthorized use of the results of Lagundi study on COVID-19

The Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) … Continue reading DOST-PCHRD warns against the unauthorized use of the results of Lagundi study on COVID-19 →

December 20, 2021

Results of Ivermectin clinical trials may benefit drug developers and the public – DOST

Results of Ivermectin clinical trials may benefit drug developers and the public – DOST

“If results are good, drug developers and the public will benefit from the local Ivermectin … Continue reading Results of Ivermectin clinical trials may benefit drug developers and the public – DOST →

October 21, 2021

VCO supports faster recovery from COVID-19 according to PCHRD-funded study

VCO supports faster recovery from COVID-19 according to PCHRD-funded study

Virgin coconut oil supports faster recovery from signs and symptoms of COVID-19, based on a … Continue reading VCO supports faster recovery from COVID-19 according to PCHRD-funded study →

June 11, 2021

DOST, DOH to probe vaccine mixed-dose approach

DOST, DOH to probe vaccine mixed-dose approach

The Department of Science and Technology (DOST) and the Department of Health (DOH) will support … Continue reading DOST, DOH to probe vaccine mixed-dose approach →

May 21, 2021

Filipino researchers are capable of world-class innovations — DOST

Filipino researchers are capable of world-class innovations — DOST

“Our very own researchers and experts are capable of producing world-class innovations and solutions,” Department … Continue reading Filipino researchers are capable of world-class innovations — DOST →

May 20, 2021

CALL FOR APPLICATIONS: PhD Program in Molecular B.

CALL FOR APPLICATIONS: PhD Program in Molecular B.

The Department of Science and Technology – Philippine Council for Health Research and Development (PCHRD), … Continue reading CALL FOR APPLICATIONS: PhD Program in Molecular B. →

March 19, 2020

REPUBLIC OF THE PHILIPPINES

All content is in the public domain unless otherwise stated.

Learn more about the Executive Order No. 2 - The order implementing Freedom of Information in the Philippines.

ABOUT GOVPH

Learn more about the Philippine government, its structure,
how government works and the people behind it.

Executive

Legislative

Judiciary

Other Agencies

Copyright © 2022 Philippine Council for Health Research and Development

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others